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ABSTRACT:  
Antifungal drugs are one of the medicines group that have the most increasing use in the past few years in human medicine sciences, 
especially with the development of AIDS epidemic and immunosuppressed diseases. In this line researchers have concentrated the 
development of new antifungal drugs that have less toxicity and more effective. The aims of this study are synthesis a few numbers of 
new derivatives of indole, benzofuran and dihydropyrimidine and all these products were evaluated for in vitro evaluation antifungal 
activity against various species of Candida, Aspergillus, and Dermatophyte by Broth Microdilution method. They also were 
investigated against exophiala dermatitidis, Pseudallescheria boydii, Penicillium marneffei, Cryptococcus neoformans and several 
species of bacteria, including Staphylococcus aureus, Escherichia coli, and Enterobacter faecalis. The obtained results were shown that 
some of them had outstanding effects. This research have also revealed that among the various synthesised compounds with different 
Structures, benzofuran derivatives were shown the best antifungal activities, while the indole and dihydropyrimidine analogues had no 
significant antifungal effect. 
Keyword: Indole, benzofuran, dihydropyrimidine, antifungal and antimicrobial activity, broth micro dilution method. 
 
INTRODUCTION 
   Although in the early twentieth century, epidemics of bacterial 
were the most important mortality factor, fungal infections were 
not nearly big factor. In the late 1960s, with the rise of antibiotic 
treatment, a serious increase in fungal infections have been 
observed. First fungal invade to tissue has been reported in the 
early years of 1800, and numerous reports of fungal diseases, 
pathogens, geographic spread of the disease are available after 
1900[1]. In recent decades, along with increasing of infectious 
diseases and weakening of the immune system such as AIDS, 
cancer, Aging, Diabetes, Cystic fibrosis, new methods of 
treatment, such as organ transplantation were developed. 
Moreover, the growth use of immunosuppressive drugs for 
treatment of autoimmune diseases and increase in chemical 
therapy against a variety of tumors are occurred. Despite of 
extensive research and huge studies to control infectious causes, 
antifungal agents have been remained as a major medical 
problem [2-5]. Contrary to the development of antifungal drugs 
in recent years, the number and range of effective treatments are 
limited and toxicity and pharmacokinetic issues are confronted 
with some problems that require new compounds to prevent or 
delay the spread of fungal agents. 
Opportunistic pathogenic fungi are divided into yeasts and 
filamentous fungi categories. Yeasts are large number of 
unicellular fungi that usually Proliferate by budding. Yeasts in 
favorable condition and immunocompromised host can create 
wide range of superficial – mucosal, Systemic, and even fatal 
disease in susceptible people. Among the pathogenic yeast, 
Candida genus, especially Candida albicans, are known as an 
opportunistic mucosal pathogen, and the fourth cause of bloody 
infections (fungemia), and also the most common cause of 
nosocomial fungal infections [2]. Other Candida species, 
especially Candida dubliniensis, in immunocompromised 
patients (such as AIDS, cancer and transplant patients) may 
cause systemic fatal infection [3]. 
Dermatophytes are a group of filamentous fungi that cause 
dermal fungal infections (Dermatophytosis). The high prevalence 
of these diseases are entitled in Iran, particularly in Fars province 
due to the background factors such as hot weather and 
occupational factors. In the recent years, infections caused by 
these fungi, especially in people who have immune deficient, are 
increasing. This causes to an atypical and Progressive lesions. 
Conventional antifungal therapies do not respond as well to the 
disease which change to chronic forms [6]. Up to the recent years 
in our country, Griseofulvin was used for the clinical forms of 
Dermatophytosis treatment; But because of many side effects of 
this drug including headache, vomiting, dizziness, it deals to 
some limits in its use. Also the prolonged use of this drug and the 
inability to completely eradicate fungal agents (this drug is 
growth inhibitor) has some limitations, too. In some species of 
Dermatophyte, the resistance to this drug was observed, thus loss 
of recovery and repeated episodes of disease was seen [7]. 
Another group of filamentous fungi is Aspergillus which is the 
major cause of fungal food spoilage and systemic mycoses in 
immunocompromised individuals [3]. Aspergillus Prevalence 
rate reached its highest level in the last two decades and has 
become one of the lethal opportunistic invasive fungal infection 
[8-9]. 
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In previous studies, a number of imidazole drugs, benzimidazole 
and triazole derivates were synthesized in Medicinal Chemistry 
College of Pharmacy, Shiraz Medical Sciences University. And it 
has been investigated in terms of antimicrobial effects in which 
some of them were suitable [10-11]. Various studies have shown 
that some indole derivatives have antimicrobial effects. In the 
present study, some of these derivatives demonstrated inhibitory 
effects at 1/0-2/0 mg/ml against Aspergillus, Candida and 
Penicillium species [12-13]. In another study, nine indole 
derivatives were evaluated in vitro examination against 
phytopathogens fungi and most of these compounds were found 
to possess efficient antifungal activities [14 ]. Some of the 
indole derivatives inhibits the differentiation and maturation of 
bacterial spores’ coats and it is effective on the control of gram-
positive bacteria [15]. The antimicrobial effects of some 
dihydropyrimidine and benzofuran derivatives were shown in 
several studies [16-18]. In a study conducted by Jiang et al. 
Significant antimicrobial effects by benzofuran derivatives on E. 
coli, Staphylococcus aureus, Bacillus cereus, and Candida 
albicans was observed [19]. In the present study some new 
benzofuran derivatives demonstrated Antimicrobial activity at 
0/1-0/5 mg/ml [20]. 
In this present study the effect of nine antifungal compounds was 
investigated on the growth of standards species of Candida, 
Aspergillus and Dermatophyte, and it also was investigated 
against Exophiala dermatitidis, Pseudallescheria boydii, 
Penicillium marneffei, Cryptococcus neoformans, and several 
species of bacteria, including Staphylococcus aureus, Escherichia 
coli and Enterobacter faecalis. At the end of this study the 
minimum inhibitory concentration and the minimum Fungicidal 
Concentrations of the effective compounds were determined, in 
the case of having low cell toxicity, they can be alternative 
replace to solve the problem of resistance to common antifungal 
drugs. 
 
MATERIALS AND METHODS 
Compounds 
 
Scheme 1. Chemical reaction for synthesis of new derivatives of 
indole, benzofuran and dihydropyrimidine 
In this study, nine synthesized compounds were determined as 
antifungal effects compared to conventional antifungal drugs. 
These compounds have been synthesized through the one pot 
three component reaction of various 1,3 di carbonyl compounds 
(3),  substituted benzaldehydes (2) and 2-naphthole (1) or aniline 
derivatives (4) in the presence of catalytic amount of formic or 
acetic acid in ethanol as solvent and reflux conditions for around 
three hours.  
The progress of reactions were monitored by TLC. After 
completion of the reactions the precipitates were collected and 
recrystallized in EtOH to afford pure products. The structures of 
products were fully confirmed by instrumental analysis and 
spectroscopic data.   
Microorganisms 
Initially, five different synthetic molecules (1A-5A) were studied 
in terms of inhibitory and fetal effects against seven standard 
strains of fungi including Candida ablicans ATCC 10261, C. 
tropicalis ATCC 750, C.glabrata ATCC 90030, C.dubliniensis 
CBS8501, C.krusei ATCC6258, Aspergillus flavus ATCC 
64025, A. fumigatus ATCC 14110.  In addition, the antibacterial 
activity of the synthesized compounds were studied against 
standard bacteria including Staphylococcus aureus ATCC 25923 
and Escherichia coli ATCC 25922, which all of them were taken 
from the reference collections of the ATCC America and CBS 
Holland companies [21-22]. 
Then four new substituted of the most effective molecule was 
synthesized (B-C) and the minimum inhibitory and lethal 
concentration of these compound was studied on standard strains 
and also susceptible and azole-resistant clinical isolates with 
using Broth microdilution method. The standard strain of yeast is 
containing Candida albicans ATCC 10261, 2730, 5982,1912, C. 
glabrata ATCC 863,2175,2192, 6144,90030, C. tropicalis ATCC 
750, C. dubliniensis  CBS  8501, ATCC 7987, 7988,9788, 
C.krusei ATCC6258. Also Exophiala dermatitidis ATCC 
120431, Cryptococcus neoformance H99 were examined. The 
standard Filamentous fungi including three strains of Aspergillus 
containing A.fumigatus ATCC 14110, A.  flavus ATCC 64025, 
A.clavatus CBS 514.65, and also Pseudallescheria boydii ATCC 
329.93, Penicillium marneffei. Moreover, the inhibitory activities 
of the mentioned compounds against Dermatophytes 
(Microsporum Canis, Trichophyton mentagrophytes and 
Trichophyton verrocosum) which were identified by 
morphological and physiological tests were also examined. At 
least three species of bacteria, including S. aureus ATCC 25923, 
Escherichia coli ATCC 25922, En. Faecalis ATCC 11700 were 
determined as well as six clinical isolates of azole-resistant 
yeasts identified by PCR-RFLP containing Candida albicans 
SUCC 2033,625,203,634, C. tropicalis SUCC611, C. 
parapselosis194 which all of them were resistant to fluconazole 
and itraconazole (MIC> 256) and the inhibitory effect of these 
drugs does not appear on them [23, 24].  The susceptibility of the 
examined isolates of fungi against flocunazole (for 
Aspergillusspecies and yeasts) or griseofulvin (for 
dermatophytes) were examined by broth microdilution method 
(rezai12). The interpretative breakpoints for susceptibility testing 
of fluconazole as recommended by clinical and laboratory 
standards institute (CLSI) were: Susceptible ≤8 µg/ml, 
Susceptible Dose Dependent 16-32 µg/ml and Resistant ≥64 
µg/ml [6].  
Determination of minimum inhibitory and fungicidal 
concentrations 
Minimal inhibitory concentrations of the synthetized agents and 
selected drugs against standard and clinical species of the fungi 
were determined by broth microdilution method as recommended 
by CLSI, with some modifications [25]. Briefly, the RPMI-1640 
(with l-glutamine and phenol red, without bicarbonate) (Sigma, 
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USA) was prepared and buffered at pH 7.0 with 0.165 mol 3-(N-
morpholino) propane sulfonic acid (MOPS) (Sigma-Aldrich, 
Steinheim, Germany). Serial dilutions of the selected compound 
(0.5-256.0 µg/mL) were prepared in 96-well microtitre trays 
using RPMI-1640 media (Sigma, St. Louis, USA) buffered with 
MOPS (Sigma, St. Louis, USA). Double dilutions of fluconazole 
were also prepared for each of the tested azol resistance strain of 
Candida with the final concentration of 0.25-128 µg/mL. Stock 
inoculums were prepared by suspending three colonies of the 
examined yeasts in 5 ml of sterile 0.85% NaCl, and adjusting the 
turbidity of the inoculums to 0.5 McFarland standard at 530 nm 
wavelength (this yields stock suspension of 1-5×10
6
 cells/ml). 
For moulds (Aspergillusspp. and dermatophytes), conidia were 
recovered from the 7-day old cultures grown on potato dextrose 
agar by a wetting loop with Tween 20. The collected conidia 
were transferred in sterile saline and their turbidity was adjusted 
to OD=0.09-0.11 that yields 0.4-5×10
6
 conidia/ml. Working 
suspension was prepared by making a 1/50 and 1/1000 dilution 
with RPMI of the stock suspension for moulds and yeasts, 
respectively. After addition of 0.1 ml of the inoculums to the 
wells, the trays were incubated at 30°C for 24-48 h in a humid 
atmosphere. 200 µl of the uninoculated medium was included as 
a sterility control (blank).  
In addition, growth controls [medium with inoculums and 5% 
(v/v) DMSO (maximum DMSO concentration) but without the 
synthetic compounds] were also included. The growth in each 
well was compared with that of the growth control well. MICs 
were visually determined and defined as the lowest concentration 
of the compounds that produced ≥50 growth inhibitions. Each 
experiment was performed in triplicate. MFCs were of the lowest 
concentration that showed either no growth or fewer than 4 
colonies, which corresponded to 98% killing activity of the initial 
inoculums. MFCs were also determined by culturing 10 µl from 
the wells showing no visible growth onto Sabouraud dextrose 
agar plates. 
 
RESULTS AND DISCUSSION 
Antibacterial and Antifungal activity 
Researches have shown that drugs with indole containing ring, 
show high biological activity against different bacteria, fungi and 
viruses. Also indole increased the effective activity of drug [26]. 
Many natural benzofuran have interesting cytotoxic and 
Pharmaceutical potential. Several synthetic compounds with this 
ring structures are associated with various biological activities 
such as antifungal, antibacterial, antiviral and antitumor. Among 
the heterocyclic compounds family, nitrogen containing 
heterocyclic are the most important categories of Medicinal 
Chemistry. Pyrimidines are an Inseparable part of DNA and 
RNA, which are demonstrated as one of the most active 
compounds in this group with a wide range of in vitro biological 
activities. According to studies, between the heterocyclic, indole 
and dihydroxy Pyrimidine have shown the highest activity [17]. 
Some Pyrimidine analogs are discussed as an antimicrobial and 
antifungal agents with high action potential [27 ]. In the 
course of our search for useful therapeutically antifungal agents, 
we synthesized some new derivatives of indole, benzofuran and 
dihydropyrimidine (scheme 2). 
 
 
 
   
 
  
 
 
 
Scheme 2. Name and Chemical structure of new derivatives of indole, benzofuran and dihydropyrimidine that synthesized for 
biological tests 
Between initial compounds which are synthesized (1A-5A), none 
of the compounds except 4A has antimicrobial effect on 
investigated microorganisms at 0.5-256 μg/ml. As shown in 
Table (1), compounds 4A has fifty percent inhibitory effects on 
the growth of tested standard species of Candida at the 
concentration of 16-128 and ninety percent growth inhibition at 
32-256 µg/ml. Also we saw the killing effect against tested 
yeasts at 64-256 μg/ml. This compound had not any effect 
against Aspergillus genus and bacteria, S. aureus and E. coli 
(Table 1). 
 
 
Table 1. The minimum inhibitory and fetal concentration of five initial synthetic molecules on seven standard yeast and mold 
fungal and two gram-negative and gram-positive bacterial species (µg/mL) 
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Continuing, regarding to compound 4A had antifungal effects on 
tested fungi, new derivates of it (B-C) was synthesized. 
Antifungal effects of new synthetic compounds against 
filamentous fungi are shown in Table (2) and against yeast fungal 
are shown in Table (3). Three B, D and E derivate had limited 
effects against tested fungi and bacteria. But the C compound 
had the most antifungal effects on the standard strains of 
Dermatophytes. It had fifty percent inhibitory effects on the 
growth of them at 4-16 μg/ml and ninety percent growth 
inhibition at 16-64 μg/ml. This compound also resulted killing 
effect on tested Dermatophytes at 32-256 μg/ml. It had the fifty 
percent growth inhibition on standard strains of Candida at 8-256 
μg/ml and ninety percent growth inhibition at 16-256 μg/ml too.  
Significant antifungal effects on azole resistant yeast strains were 
observed too and it had Fifty percent growth inhibition at 32-128 
μg/ml on, and ninety percent growth inhibition at 128-256 μg/ml. 
Compared with other yeasts, this compound showed fifty percent 
inhibitory effect on Exophiala dermatitidis at 16 μg/ml and 
Ninety percent inhibitory effect at 32 μg/ml. Also it killed this 
strain at 128 μg/ml.  
These drugs effect on the filamentous fungi, Aspergillus species, 
Pseudallescheria boydii, Penicillium marneffei and microbial 
standard strains under study was not observed. 
DISCUSSION 
Among the initial synthesized substances, two compounds which 
known as following structures: 5-(2-(4-nitrophenyl)naphtho[2,1-
b]furan-1-yl) pyrimidine-2,4,6(1H,3H,5H)-trione  (1A), and 2-(5-
chloro-3-(4-nitrophenyl)-1H-indol-2-yl)cyclohexane-1,3-dione  
(4A), are from Naphthofurane derivatives, which are only the 
compound 4A with contains of phenyl ring in C-2 position of 
benzofurane and also cyclohexene-1,3-dione in C-3 position of 
this ring with two methyl group substrate in the concentration 
range of 0.5-256 µg/ml have antifungal and antibacterial effect 
on tested microorganisms. The antifungal effect investigation of 
initial compounds on yeasts and standard microbial and mold 
fungal are given in table (1). compound 4A had 50% growth 
inhibitory effect on standard strain of candida yeasts at 16-128 
µg/ml, besides, had 90% growth inhibitory effect at 32-256 
µg/ml. additionally, we have been considered the fetal effects on 
tested  yeasts at 64-256 µg/ml.  In contrast, this compound had 
no effect on strand strain of Aspergillus, and bacterial species 
containing Staphylococcus aureus and Escherichia coli. 
Localizing of nitro-group on C-4 phenyl ring and substitution of 
pyrimidine ring instead of cyclohexene-1,3-dione on 1A 
compound, revealed to antifungal declension properties.  
Table 2. The minimum inhibitory and fetal concentration of four secondary synthetic molecules on fungal standard species of mold 
and bacteria (µg/mL) 
 
 
 
Compound 
 
 
 
 
 
Fungi 
(number of strains) 
 
 
 
 
1A 
 
 
 
2A 
 
3A 
 
4A 
 
5A 
MIC
50 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MFC MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MFC 
F
il
am
en
to
u
s 
  
  
  
  
  
  
  
  
  
  
  
Y
ea
st
 
Candida albicans     
ATCC 10261 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
16 32 64 >25
6 
>25
6 
>256 
Candida 
dubliniensis 
CBS8501 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
32 128 256 >25
6 
>25
6 
>256 
andida 
glabrata 
ATCC 90030 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
32 64 64 >25
6 
>25
6 
>256 
C.tropicalis 
ATCC 750 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
64 128 128 >25
6 
>25
6 
>256 
Candida  krusei 
ATCC6258 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
128 256 256 >25
6 
>25
6 
>256 
 MIC
50 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MFC MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MFC 
Aspergillus 
fumigates 
ATCC 14110 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>256 
spergillus  
flavus 
ATCC 64025 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>256 
Bacteria(number of 
strains) 
MIC
50 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MFC MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MF
C 
MI
C50 
MI
C90 
MFC 
G
ra
m
 p
o
si
ti
ve
 
an
d
 
G
ra
m
 n
eg
at
iv
e Staphylococ
cus aureus 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>256 
Escherichia 
coli 
 
>25
6 
>256 >25
6 
>256 >256 >256 >25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>25
6 
>256 
J. of Advancement in Medical and Life Sciences                Volume 4/Issue 4                        ISSN: 2348-294X                 5 
 
 
One of the reasons shall be depend on electronegative effect of 
nitro group on phenyl ring and varying in polarization of 
molecule. 
The compounds of: 2-(5-chloro-3-(4-chlorophenyl)-1H-indol-2-
yl)-5,5-dimethylcyclohexane-1,3-dione (2A) and 2-(5-chloro-3-
(4-nitrophenyl)-1H-indol-2-yl)cyclohexane-1,3-dione (3A), are 
from indole derivatives. According to various extend efficiency 
of compounds, reported in literatures, we had expected that the 
2A and 3A structures had an appropriate effect as antifungal and 
antimicrobial efficiency. However no salient effects have been 
shown of these compounds on discussed strains. This effect have 
explanation as following reason that, the substitution of several 
chemical groups in indole substances resulted decreasing or 
increasing in molecular spatial and charge distribution, 
conjunction to target molecule proportion and also causes 
antifungal and antimicrobial effects. The presence of ρ-
chlorophenyl in C-3 position on indole ring in 2A compound in 
comparison of ρ-nitrophenyl group in the same structure at 
mentioned position in 3A compound had contemporary effect, 
however the presence of two methyl group in cyclohexene-1,3-
dione ring in 2A compound, couldn`t improve the antifungal and 
antimicrobial properties. Compound 5-(3-(4-chlorophenyl)-5-
nitro-1H-indol-2-yl) pyrimidine 2,4,6(1H,3H,5H)-trione (5A) is 
from dihydropyrimidine derivatives with indole ring. According 
to investigations in hetrocycles, indoles and dihydropyrimidine 
had the most activities between these structures [20]. It seems 
that more of dihydropyrimidine derivatives had antifungal 
activities in comparison of antibacterial effects. Besides, neither 
antifungal nor antibacterial effects exhibited from compound 5A. 
In contrast of our imagination which expected to show 
considerable effects in the mentioned compound by presence of 
dihydropyrimidine and indole ring, simultaneously, the presence 
of nitro group in C-5 position on indole ring revealed to 
disappear the biological effect of the compound. In addition this 
structure had no consider effects, like (2A) compound, that might 
be the presence of chloro and nitro group in the structure in C-5 
position of indole ring have similar effect on deactivation of 
molecule. As reported literatures about pyrimidines activations 
board, which are C-4, and C-5 of these molecules, and since 
existing of various groups in this positions, the biological effects 
are more undertaken of these groups. It is be notable that in 5A 
structure the C-5 position of pyrimidine ring occupied by indole 
substrate, and it seems that the most sterically inhibit exhibited 
for the molecule to annihilate the biological effects. As a result 
an appropriated compound between these initial classify 
compounds in this study, is 4A compound growth inhibitory 
effect on candidate standard strain. This compound had no effect 
on strand strain of Aspergillus, Staphylococcus aureus and 
Escherichia coli. In the next stage, different derivatives from the 
presence compound was synthesized and examined from the 
 
 
 
Compound 
 
 
 
 
Fungi 
(number of strains) 
 
 
B 
 
C 
 
D 
 
 
E 
MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC 
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
  
 f
il
am
en
to
u
s 
Aspergillus 
fumigates ATCC 
14110 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Aspergillus  flavus        
ATCC 64025 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Aspergillus 
clavatus 
CBS 514.65 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
pseudallescheria 
boydii 
CBS 329.93 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Penicillium 
marneffei 
 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Microsporum 
canis 
 
>256 >256 >256 16 64 256 >256 >256 >256 >256 >256 >256 
Trichophyton 
mentagrophytes 
>256 >256 >256 16 64 256 >256 >256 >256 >256 >256 >256 
Trichophyton 
verrucosum 
>256 >256 >256 4 16 32 8 64 64 >256 >256 >256 
Bacteria(number of 
strains) 
MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC MIC5
0 
MIC9
0 
MFC 
  
 G
ra
m
 
P
o
si
ti
ve
 
  
  
  
  
  
an
d
  
  
 G
ra
m
 
n
eg
at
iv
e 
Staphylococcus 
aureus 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Enterobacter 
 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Escherichia coli 
 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
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antifungal and antibacterial properties approach. The antifungal 
activities of novel synthesized compounds in relation of strain 
fungal, was shown in table (1-2) and the next, in relation of yeast 
fungal was observed in table (3).  
Table 3. The minimum inhibitory and fetal concentration of four secondary synthetic molecules on standard yeast species and azole 
resistant strains (µg/mL) 
 
In the compound of 5,5-dimethyl-2-(2-(4-nitrophenyl)naphtha 
[2,1-b]furan-1-yl)cyclohexane-1,3-dione  (B), by addition of 
nitro group in C-4 of phenyl ring in relation of (4A) compound, 
we had released the antifungal and antimicrobial effects. In the 
compound, 2-(2-(4-chlorophenyl)naphtho[2,1-b] furan-1-yl)-5,5-
dimethylcyclohexane-1,3-dione (C), by addition of chloro group 
in C-4 of phenyl ring in relation of (4A) compound, considerable 
effects was observed on standard strain Dermatophytes, and At 
4-16 µg/ml, resulted 50% growth inhibitory, besides, had 90% 
growth inhibitory effect at 16-64 µg/ml. This compound also, 
was annihilated treated Dermatophytes in the range of 32-256 
µg/ml. the mentioned compound had considerable effects on 
 
 
 
Compound 
 
 
Fungi(number 
of strains) 
YEAST 
 
 
B 
 
C 
 
D  
E 
MIC5
0 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MF
C 
MIC5
0 
MIC9
0 
MF
C 
Candida 
albicans 
ATCC 10261 
>256 >256 >256 32 128 256 256 >256 >256 >256 >256 >256 
Candida 
albicans 
ATCC5982 
>256 >256 >256 256 >256 >256 >256 >256 >256 >256 >256 >256 
Candida 
albicans 
ATCC2730 
>256 >256 >256 64 256 >256 >256 >256 >256 >256 >256 >256 
Candida 
albicans 
ATCC1912 
>256 >256 >256 128 >256 >256 >256 >256 >256 >256 >256 >256 
Candida 
dubliniensis 
CBS8501 
>256 >256 >256 16 64 >256 128 >256 >256 >256 >256 >256 
Candida 
dubliniensis 
ATCC7987 
>256 >256 >256 8 16 256 >256 >256 >256 >256 >256 >256 
Candida 
dubliniensis 
ATCC7988 
>256 >256 >256 16 64 128 >256 >256 >256 >256 >256 >256 
Candida 
dubliniensis 
ATCC9788 
>256 >256 >256 128 >256 >256 >256 >256 >256 >256 >256 >256 
Candida 
glabrata 
ATCC 90030 
>256 >256 >256 64 256 >256 128 >256 >256 >256 >256 >256 
Candida 
glabrata 
ATCC863 
>256 >256 >256 64 256 >256 >256 >256 >256 >256 >256 >256 
Candida 
glabrata 
ATCC6144 
>256 >256 >256 256 >256 >256 >256 >256 >256 >256 >256 >256 
Candida 
glabrata 
ATCC2192 
>256 >256 >256 64 256 >256 >256 >256 >256 >256 >256 >256 
Candida 
glabrata 
ATCC2175 
>256 >256 >256 64 256 >256 >256 >256 >256 >256 >256 >256 
C.tropicalis 
ATCC 750 
>256 >256 >256 128 256 256 128 >256 >256 64 128 256 
Candida  krusei 
ATCC6258 
>256 >256 >256 8 32 256 128 >256 >256 64 >256 >256 
Candida 
albicans * 
SUCC2033 
>256 >256 >256 128 >256 >256 >256 >256 >256 >256 >256 >256 
Candida 
albicans* 
SUCC625 
>256 >256 >256 128 >256 256 >256 >256 >256 >256 >256 >256 
C.tropicalis* 
SUCC611 
>256 >256 >256 64 256 >256 >256 >256 >256 >256 >256 >256 
Candida 
albicans* 
SUCC203 
>256 >256 >256 32 128 256 128 256 256 >256 >256 >256 
Candida 
parapsilosis* 
SUCC194 
>256 >256 >256 64 128 >256 >256 >256 >256 >256 >256 >256 
Candida 
albicans * 
SUCC634 
>256 >256 >256 128 256 >256 >256 >256 >256 >256 >256 >256 
Cryptococcus 
neoformans  
H99 
>256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 >256 
Exophiala 
dermatitidis 
CBS 120431 
>256 >256 >256 16 32 128 >256 >256 >256 >256 >256 >256 
*Azol resistance 
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studied yeasts in relation to another synthesized derivatives and 
at  8-256 µg/ml, resulted 50% growth inhibitory on candidate 
standard strain, Moreover, had 90% growth inhibitory effect at 
16-256 µg/ml. In some substances hadn`t observed 90% growth 
inhibitory effect. The results are comparable with 4A compound. 
The above compound was annihilated some strain yeast (Candida 
albicans, C. tropicalis, C. dubliniensis, C.krusei). The killing 
effects on some strains in ratio 4A compound demonstrated 
decreasing statement.  
In some of the azole resistance strain of yeasts, observed a 
substantial antifungal effects. Compound C resulted 50% growth 
inhibitory, at 32- 128 µg/ml, and 90% growth inhibitory effect at 
128-256 µg/ml.  
In comparison of candidate yeasts, Compound C obtained 50% 
growth inhibitory at 16 µg/ml, and 90% growth inhibitory effect 
at 32 µg/ml for Exophiala dermatitidis. Furthermore, 
decomposition of this fungal at 128 µg/ml, attended to this 
phenomena, we never seen any effect on mold fungi containing 
Aspergillus, Pseudallescheria boydii, Penicillium marneffei, and 
standard microbial species. 
In compound: 2-(2-(4-chlorophenyl)naphtho[2,1-b] furan-1-
yl)cyclohexane-1,3-dione  (D), by elimination of dimethyle from 
cyclohexene-1,3-dione ring, in relation of compound C, the 
biological effects have been decreased potentially, and we had 
established only 50% growth inhibitory at 8 µg/ml, and also 90% 
growth inhibitory effect at 64 µg/ml for Trichophyton species. 
However we haven`t considered the fetal effects on treated 
Dermatophytes at 64 µg/ml. besides,  50% growth inhibitory 
effect observed on candida standard strain at 128-256 µg/ml. In 
addition compound: 6-hyrdoxy-2-(2-4-nitrophenyl)naphtho[2,1-
b]furan-1-yl)pyrimidine-2,4(1H,3H)-dione  (E) have not showed 
antifungal and antibacterial effects, like B compound. We have 
monitored only 50% growth inhibitory effect on two yeast 
species (Candida tropicalis, C.krusei) at 64 µg/ml. It means that, 
occupation of C-3 position on indole ring with 
dihydropyrimidine substrate, instead of cyclohexene-1,3-dione 
couldn`t be optimize and stimulate biological efficiency. 
 
CONCLUSION 
The observation of structural associations and efficiency of these 
substances demonstrates that, 4A and C compounds had an 
excellent effect on most investigated strain fungal, except strand 
fungal and microbial strains, which are evident in some cases 
growth inhibitory effect and another case fetal effects of 
aforementioned molecules. In addition in comparison of 
Fluconazole and Itraconazole, these substances showed an 
appropriate effect on azole resistance strains. These structures 
have both the same substrate cyclohexene-1,3-dione in C-3 
position of naphtofurane ring, and the variance of them is 
presence of chloro group on ρ-position of phenyl ring conjugated 
to naphthofurane moiety which had not considerable effect on 
results, so since of more identical structure conformation, carried 
out contemporary efficiency, approximately. Moreover 
compound C indicated growth inhibitory and fetal effects on 
Dermatophytes fungal. So, in relation of common 
antidermatophytes drugs, like Griseofulvin, which are growth 
inhibitor of these fungal have priority efficiency. 
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